Introduction:
The Global RNAi Technology Market, as reported by TechSci Research in their “RNAi Technology Market – Global Industry Size, Share, Trends, Competition Forecast … Read More
As an important drug modality, the development of oligonucleotides will continue to expand in the coming years. Oligonucleotide drugs are a class of therapeutic agents composed of short nucl… Read More
Editor’s Note: The article below from The Epoch Times is exactly why we partnered with Prepper All Naturals to provide long-term storage beef to our readers. Their CEO, U.S. Army veter… Read More
The central nervous system (CNS), consisting of the brain and spinal cord, is the command center of the human body. It assures cognitive, sensory, and motor functions through a dense network… Read More
The biopharmaceutical CMO and CRO market size is poised to grow by $ 59.13 billion by 2030 from $ 33.4 Billion in 2022, exhibiting a CAGR of 7.4% during the forecast period 2022 t… Read More
Molecular genetics delves into the structure and function of genes at a molecular level, offering profound insights into biology, medicine, and technology. Its real-world applications span… Read More
Gene Therapy for Cancer Treatment in 2023. Gene therapy has emerged as a promising approach in cancer treatment, offering targeted and personalized therapies. This article explores the conce… Read More
In molecular biology, DNA and RNA are the building components of life’s genetic code. In all living things, DNA and RNA store, transmit and express genetic information. Understanding D… Read More
What is Huntington’s Disease?
Huntington’s Disease (HD) is a rare, inherited neurodegenerative disorder that affects the brain. It is caused by a mutation in the huntingtin gene… Read More
The core technologies of oligonucleotide drug development include sequence design, synthesis and modification, isolation and purification, and delivery techniques. The production of oligonuc… Read More
Research Nester released a report titled “RNAi Technology Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global RNAi techn… Read More
Research Nester released a report titled “RNAi Technology Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global RNAi techn… Read More
Owing to their vast potential in controlling disease-associated gene expression, RNAi therapeutics have emerged as a key segment of the market; several big pharma players have undertaken RNA… Read More
Biologics Market is projected to be worth USD 432.45 Billion by 2030, registering a CAGR of 3.2% during the forecast period (2022-2030), the market was valued at USD 325.70 Billion in 2021.T… Read More
Gene therapy can be defined as the set of techniques that use nucleic acids (DNA, RNA, or their variants) to replace, correct, or inhibit an endogenous gene in the cells of the organism or… Read More
The Nobel Prize is a set of international awards that are given annually to individuals who have made outstanding contributions in the fields of physics, chemistry, medicine or physiology… Read More
“The report on Liposome Drug Delivery Market was recently published by SDKI, which includes the latest market trends, current and future opportunities along with the factors… Read More
Alnylam Pharmaceuticals, a leading RNA interference (RNAi) therapeutics biopharmaceutical company, announced it received approval from the US Food and Drug Administration (FDA) for its RNAi… Read More
In the previous industry primer article, we covered the pharmaceutical industry. This article will cover a closely related sector, biotechnology. Biotechnology companies also mainly operate… Read More
Gene therapy is being extensively used to
treat several diseases like cancer, cystic fibroses, heart diseases, diabetes,
AIDS, and Hemophilia. Increasing popularity of gene therapy owes to t… Read More
Kenneth Research has evaluated the current market opportunities in Central Nervous System Therapeutic Market in the healthcare industry for the forecast period 2022-2031, which also includes… Read More
Rare and rheumatic disease-focused biotech Horizon Therapeutics has received expanded approval from the US Food and Drug Administration (FDA) for its gout injection Krystexxa (pegloticase) t… Read More
Oligonucleotides are short synthetic DNA or RNA polymers, which modulate gene expression through Watson-Crick base pairing with targeted nucleic acids. Oligonucleotides regulate gene express… Read More
This article New ‘gene silencer’ drug reduce cholesterol by over 50 percent appeared first on Project Topics.
The findings come from the largest trial yet to test the safety and… Read More
If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. The development and widespread adoption of new technologies is key… Read More
Nucleic acid and nucleic acid drugs
Nucleic acid is the carrier of life genetic information. It has both the storage function of life information and the active function of biocatalysis… Read More
The global Biopharmaceuticals Contract Manufacturing Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, t… Read More
In rare disease trials, it’s not always feasible to choose clinically-relevant endpoints to measure the efficacy of a new therapeutic. Often, the potential patient pool for a given tri… Read More
The study involved four major activities to estimate
the current size of the global active pharmaceutical ingredient market.
Exhaustive secondary research was done to collect information on… Read More
Now, UC San Francisco researchers have devised a CRISPR-based complement called SLICE, that will concede scientists to fast consider a duty of any and any gene in “primary” defen… Read More